Concepedia

Michael D. Serby

MD

Statistics

Publications

15

Citations

826

H-Index

14

Active since

2004

Affiliations

Abbott Fund(Current)

Abbott (United Kingdom)

AbbVie (United States)

Abbott (United States)

Michael D. Serby is an author at Abbott Fund specializing in pharmacology, pharmacy, and medicinal chemistry.

Publications per year

2004–2016

15

Publications

15

Aminopyridine-Based c-Jun N-Terminal Kinase Inhibitors with Cellular Activity and Minimal Cross-Kinase Activity

Bruce G. Szczepankiewicz, Christi Kosogof, Lissa T.J. Nelson et al. · Journal of Medicinal Chemistry · 2006 · 160 citations · Full text

, , +15

Discovery of Potent, Selective, Orally Bioavailable Stearoyl-CoA Desaturase 1 Inhibitors

Gang Liu, Jennifer C. Freeman, Bo Liu et al. · Journal of Medicinal Chemistry · 2007 · 118 citations · Full text

, , +17

Metabolism and Disposition of a Novel B-Cell Lymphoma-2 Inhibitor Venetoclax in Humans and Characterization of Its Unusual Metabolites

Hong Liu, Melissa J. Michmerhuizen, Yanbin Lao et al. · Drug Metabolism and Disposition · 2016 · 89 citations

, , +16

Isoxazole carboxylic acids as protein tyrosine phosphatase 1B (PTP1B) inhibitors

Hongyu Zhao, Gang Liu, Zhili Xin et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 81 citations · Full text

, , +14

Discovery of piperidine-aryl urea-based stearoyl-CoA desaturase 1 inhibitors

Zhili Xin, Hongyu Zhao, Michael D. Serby et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 76 citations · Full text

, , +11

1–5 of 15